These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 29867460)

  • 1. Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study.
    Lai KC; Chen SJ; Lin CS; Yang FC; Lin CL; Hsu CW; Huang WC; Kao CH
    Front Pharmacol; 2018; 9():448. PubMed ID: 29867460
    [No Abstract]   [Full Text] [Related]  

  • 2. Amiodarone use is associated with increased risk of stroke in patients with nonvalvular atrial fibrillation: a nationwide population-based cohort study.
    Chen WC; Chen WC; Chen CY; Wu BR; Cheng WC; Lin KH; Hsia TC; Chen W; Chen CH; Muo CH; Liao WC; Li CH
    Medicine (Baltimore); 2015 May; 94(19):e849. PubMed ID: 25984674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does digoxin increase the risk of ischemic stroke and mortality in atrial fibrillation? A nationwide population-based cohort study.
    Chao TF; Liu CJ; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Chiang CE; Chen SA
    Can J Cardiol; 2014 Oct; 30(10):1190-5. PubMed ID: 25262860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association between duration of digoxin use and adverse outcomes among Chinese patients with atrial fibrillation].
    Chang SS; Gao Y; Xia SJ; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):728-734. PubMed ID: 32957754
    [No Abstract]   [Full Text] [Related]  

  • 5. Digoxin for atrial fibrillation and atrial flutter: A systematic review with meta-analysis and trial sequential analysis of randomised clinical trials.
    Sethi NJ; Nielsen EE; Safi S; Feinberg J; Gluud C; Jakobsen JC
    PLoS One; 2018; 13(3):e0193924. PubMed ID: 29518134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data.
    Hirai T; Kasai H; Naganuma M; Hagiwara N; Shiga T
    BMC Pharmacol Toxicol; 2022 Feb; 23(1):14. PubMed ID: 35144695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation.
    Siu CW; Lau CP; Lee WL; Lam KF; Tse HF
    Crit Care Med; 2009 Jul; 37(7):2174-9; quiz 2180. PubMed ID: 19487941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of Death and Stroke in Patients Undergoing Hemodialysis With New-Onset Atrial Fibrillation: A Competing-Risk Analysis of a Nationwide Cohort.
    Shih CJ; Ou SM; Chao PW; Kuo SC; Lee YJ; Yang CY; Tarng DC; Lin CC; Huang PH; Li SY; Chen YT
    Circulation; 2016 Jan; 133(3):265-72. PubMed ID: 26680239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influenza vaccination might reduce the risk of ischemic stroke in patients with atrial fibrillation: A population-based cohort study.
    Kao PF; Liu JC; Hsu YP; Sung LC; Yang TY; Hao WR; Lin YC; Wu SY
    Oncotarget; 2017 Dec; 8(68):112697-112711. PubMed ID: 29348857
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin in atrial fibrillation: report from the Stockholm Cohort study of Atrial Fibrillation (SCAF).
    Friberg L; Hammar N; Rosenqvist M
    Heart; 2010 Feb; 96(4):275-80. PubMed ID: 19710030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of digoxin versus low-dose amiodarone for ventricular rate control in patients with chronic atrial fibrillation.
    Tse HF; Lam YM; Lau CP; Cheung BM; Kumana CR
    Clin Exp Pharmacol Physiol; 2001; 28(5-6):446-50. PubMed ID: 11380520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF).
    Washam JB; Stevens SR; Lokhnygina Y; Halperin JL; Breithardt G; Singer DE; Mahaffey KW; Hankey GJ; Berkowitz SD; Nessel CC; Fox KA; Califf RM; Piccini JP; Patel MR;
    Lancet; 2015 Jun; 385(9985):2363-70. PubMed ID: 25749644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
    Joseph AP; Ward MR
    Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prediction of ischemic stroke among atrial fibrillation patients with end-stage renal disease requiring dialysis.
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Liao JN; Chen TJ; Lip GY; Chen SA
    Heart Rhythm; 2014 Oct; 11(10):1752-9. PubMed ID: 24952148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients With Ischemic Stroke and Incident Atrial Fibrillation: A Nationwide Cohort Study.
    Fauchier L; Clementy N; Pelade C; Collignon C; Nicolle E; Lip GY
    Stroke; 2015 Sep; 46(9):2432-7. PubMed ID: 26251249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
    Flaker G; Lopes RD; Hylek E; Wojdyla DM; Thomas L; Al-Khatib SM; Sullivan RM; Hohnloser SH; Garcia D; Hanna M; Amerena J; Harjola VP; Dorian P; Avezum A; Keltai M; Wallentin L; Granger CB;
    J Am Coll Cardiol; 2014 Oct; 64(15):1541-50. PubMed ID: 25301455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of practice patterns in the treatment of atrial fibrillation among the commercially insured.
    Liu J; Sylwestrzak G; Barron J; Rosenberg A; White J; Whitney J; Redberg R; Malenka D
    Curr Med Res Opin; 2014 Sep; 30(9):1707-13. PubMed ID: 24809834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonapnea sleep disorders are associated with subsequent ischemic stroke risk: a nationwide, population-based, retrospective cohort study.
    Huang WS; Tsai CH; Lin CL; Sung FC; Chang YJ; Kao CH
    Sleep Med; 2013 Dec; 14(12):1341-7. PubMed ID: 24211072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of ischemic stroke after atrial fibrillation diagnosis: A national sample cohort.
    Son MK; Lim NK; Kim HW; Park HY
    PLoS One; 2017; 12(6):e0179687. PubMed ID: 28636620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous Amiodarone versus Digoxin in Atrial Fibrillation Rate Control; a Clinical Trial.
    Shojaee M; Feizi B; Miri R; Etemadi J; Feizi AH
    Emerg (Tehran); 2017; 5(1):e29. PubMed ID: 28286836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.